PANICHI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 8.789
AS - Asia 4.510
EU - Europa 4.501
SA - Sud America 600
AF - Africa 220
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.639
Nazione #
US - Stati Uniti d'America 8.531
CN - Cina 1.432
SG - Singapore 1.353
PL - Polonia 1.272
IT - Italia 1.050
HK - Hong Kong 787
SE - Svezia 623
BR - Brasile 523
BG - Bulgaria 318
DE - Germania 294
KR - Corea 259
CA - Canada 220
TR - Turchia 203
VN - Vietnam 203
UA - Ucraina 199
GB - Regno Unito 178
FI - Finlandia 167
RU - Federazione Russa 157
NG - Nigeria 105
CH - Svizzera 87
IN - India 73
FR - Francia 45
JP - Giappone 35
AR - Argentina 27
SN - Senegal 27
IQ - Iraq 26
BD - Bangladesh 24
BE - Belgio 24
CI - Costa d'Avorio 24
MX - Messico 18
NL - Olanda 18
EC - Ecuador 17
AU - Australia 15
AT - Austria 13
MA - Marocco 13
PK - Pakistan 13
SA - Arabia Saudita 13
ZA - Sudafrica 13
EG - Egitto 12
VE - Venezuela 12
ID - Indonesia 11
KE - Kenya 10
UZ - Uzbekistan 10
ES - Italia 9
MY - Malesia 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
LT - Lituania 7
OM - Oman 7
CL - Cile 6
CZ - Repubblica Ceca 6
IR - Iran 6
TW - Taiwan 6
GR - Grecia 5
HN - Honduras 5
IE - Irlanda 5
IL - Israele 5
PH - Filippine 5
PT - Portogallo 5
TH - Thailandia 5
JM - Giamaica 4
NP - Nepal 4
RS - Serbia 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
DZ - Algeria 3
ET - Etiopia 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
RO - Romania 3
AM - Armenia 2
CR - Costa Rica 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
PY - Paraguay 2
AI - Anguilla 1
AL - Albania 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GF - Guiana Francese 1
GM - Gambi 1
GT - Guatemala 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PE - Perù 1
Totale 18.635
Città #
Ashburn 900
Hong Kong 779
Singapore 759
Fairfield 734
Chandler 690
Santa Clara 633
Woodbridge 589
Ann Arbor 537
Milan 486
Houston 461
Dallas 447
Sofia 318
Shanghai 308
Hefei 296
Seattle 289
Wilmington 285
Jacksonville 254
Seoul 252
Beijing 232
New York 223
Cambridge 216
Ottawa 185
Boardman 181
Princeton 158
Lawrence 144
Los Angeles 130
Medford 128
Izmir 123
Nanjing 115
Lagos 104
Bern 82
Dong Ket 80
The Dalles 65
Columbus 62
Istanbul 59
Des Moines 54
Rome 52
Council Bluffs 51
Jüchen 51
Buffalo 49
Redondo Beach 48
Chicago 43
Nanchang 39
Dearborn 37
São Paulo 35
Ogden 34
Falls Church 33
London 32
San Diego 32
Munich 31
Boulder 29
Kunming 29
Hebei 28
Serra 28
Tokyo 28
Dakar 27
Frankfurt am Main 26
Lancaster 26
Florence 25
Abidjan 24
Helsinki 22
Shenyang 21
San Jose 20
Brussels 19
Norwalk 19
Changsha 18
Nuremberg 18
Ho Chi Minh City 17
Rio de Janeiro 17
Warsaw 17
Guangzhou 16
Belo Horizonte 15
Jiaxing 15
Montreal 15
Falkenstein 13
Pisa 13
Pune 13
Redwood City 13
Tianjin 13
Fuzhou 12
Turku 12
Baghdad 11
Hangzhou 11
Hanoi 11
Orange 11
Stockholm 10
Washington 10
Ankara 9
Boston 9
Cascina 9
Chennai 9
Curitiba 9
Detroit 9
Mumbai 9
Nairobi 9
Verona 9
Brasília 8
Denver 8
Indiana 8
Jinan 8
Totale 12.710
Nome #
Effect of simvastatin therapy on inflammatory markers and lipids in pre-dialysis patients 1.463
C reactive protein in patients with chronic renal diseases 241
Biomarkers of chronic inflammatory state in uremia and cardiovascular disease. 177
Dimethylarginine levels and nutritional status in hemodialysis patients 173
RENAL EFFECTS OF ENALAPRIL IN HYPERTENSIVE PATIENTS WITH GLOMERULONEPHRITIS 171
Caffeic acid, a phenol found in white wine, modulates endothelial nitric oxide production and protects from oxidative stress-associated endothelial cell injury 170
Anti-aggregating activity of trans-and cis-resveratrol 169
Effect of a soy protein diet on serum lipids of renal transplant patients 169
Simvastatin (S) and fluvastatin (F) modulate cytokines production in isolated human monocytes from chronic renal failure patients 166
Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function 165
Antiproteinuric effect of Losartan in patients with chronic renal diseases 163
Echocardiographyc ultrasonic tissue characterization in a case of l’abry’s disease following renal transplantation 162
Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension. 161
Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients 160
Effect of simvastatin therapy on inflammatory markers and lipids in pre-dialysis patients 158
The biological response to online Hemodiafiltration 158
LACK OF NOCTURNAL SERUM THYROTROPIN (TSH) SURGE IN PATIENTS WITH CHRONIC-RENAL-FAILURE UNDERGOING REGULAR MAINTENANCE HEMOFILTRATION - A CASE OF CENTRAL HYPOTHYROIDISM 158
Outcomes of vascular access care and surgery managed by interventional nephrologists: A twelve-year experience 157
Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial 156
A VITAMIN E-COATED POLYSULFONE MEMBRANE REDUCES SERUM LEVELS OF INFLAMMATORY MARKERS AND ESAs RESISTANCE IN HAEMODIALYSIS PATIENTS: RESULTS FROM A RANDOMIZED CROSS-OVER MULTICENTRE TRIAL 152
Iodine and thyroid dysfunction in uremia 152
Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-Thy 1 glomerulonephritis 151
MECHANISMS OF ACID-BASE HOMEOSTASIS IN ACETATE AND BICARBONATE DIALYSIS, LACTATE HEMOFILTRATION AND HEMODIAFILTRATION 150
Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study 150
Soy protein diet improves endothelial dysfunction in renal transplant patients 149
The Pisa experience of renal biopsies, 1977-2005 148
1,25-dihydroxyvitamin D-3 dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium 148
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study 147
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 146
Acute CYA-induced ATP depletion is prevented by pretreatment with L-propionylcarnitine in isolated and perfused rat kidney 146
An overview of haemodialysis and oxidant stress 145
ULTRAFILTRATION - A RATIONAL TREATMENT FOR HEART-FAILURE 141
Vascular calcifications as a footprint of increased calcium load and chronic inflammation in uremic patients: a need for a neutral calcium balance during hemodialysis? 141
Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up 141
Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing 140
Painful neuropathy, monoclonal gammopathy and amyloid deposit: response to treatmente in 3 cases. 140
Biocompatibility evaluation of polyamide hemofiltration 140
Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis 140
Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril 137
The link of biocompatibility to cytokine production 136
Cytokine production in haemodiafiltration: a multicentre study 135
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease 134
C-reactive protein as a marker of chronic inflammation in uremic patients 133
Correction to: Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus" 132
PAIRED FILTRATION DIALYSIS (PFD) - BIOCOMPATIBILITY, DIALYTIC EFFICIENCY AND CLINICAL TOLERANCE IN A LONG-TERM MULTICENTER TRIAL 132
Theoretical calculation of optimal depth in the percutaneous native kidney biopsy to drastically reduce bleeding complications and sample inadequacy for histopathological diagnosis 132
Nutritional knowledge in hemodialysis patients and nurses: focus on phosphorus. 132
RAASi Therapy Attenuates the Association between 24-h Urinary Potassium Excretion and Dietary Potassium Intake in CKD Patients 131
Automatic Adaptive System Dialysis for Hemodialysis-Associated Hypotension and Intolerance: A Noncontrolled Multicenter Trial 131
A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial 131
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy 131
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial 129
On-Line Hemodiafiltration in the Large RISCAVID Study 129
Study of serum 3,5,3'-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness 129
Treatment of idiopathic membranous nephropathy (MNG) with high dose intravenous gammaglobulin: results of a multicenter non-randomized and non-controlled trial. 129
C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure 128
Renal transplantation in patients with Fabry disease 127
In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients 127
The social cost of chronic kidney disease in Italy 127
Oxidative stress and inflammatory reaction modulation by white wine 126
Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship 125
Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvascular injury 125
Urotensin II is related with atherogenic risk in hemodialysis patients 125
Divert to ULTRA: Differences in infused volumes and clearance in two on-line hemodiafiltration treatments 125
1,25-Dihidroxyvitamin D3 dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium 125
Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study 125
Economic impact of ferric carboxymaltose in haemodialysis patients 124
Protective effect of L-propionylcarnitine on cyclosporine-induced nephrotoxicity. 124
Online Hemodiafiltration Inhibits Inflammation-Related Endothelial Dysfunction and Vascular Calcification of Uremic Patients Modulating miR-223 Expression in Plasma Extracellular Vesicles 123
Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients 123
Severe hypotension during hemofiltration in an uremic patient with metabolic alkalosis 122
Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity 122
C-reactive protein and interleukin 6 are related to renal function in chronic renal failure 121
Pure red cell aplasia induced by epoetin zeta 120
Plasma C-reactive protein in haemodialysis 120
Echocardiographic ultrasonic tissue characterization in a case of Fabry's disease following renal transplantation 120
Geriatric nutritional risk index is a strong predictor of mortality in hemodialysis patients: data from the Riscavid cohort. 120
Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study 120
CELLULAR EXPRESSION OF LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 AND INTERCELLULAR-ADHESION MOLECULE-1 IN NORMAL KIDNEY STRUCTURES AND IN RENAL-CANCER - POSSIBLE SIGNIFICANCE IN IMMUNE-RESPONSE AND IN THE CLINICOPATHOLOGICAL CORRELATION 118
Results from the RISCAVID study: is haemodiafiltration associated with improved survival? Reply 117
INTRAVENOUS IMMUNOGLOBULIN THERAPY OF MEMBRANOUS NEPHROPATHY - EFFICACY AND SAFETY 115
Inflammation, CRP, calcium overload and a high calcium-phosphate product: a 'liaison dangereuse' 115
Ultrasonic tissue characterization (backscatter) in the analysis of left ventricular myocardial intrinsic function in systemic amyloidosis 115
Effects of calcitriol on the immune system: New possibilities in the treatment of glomerulonephritis 114
Effects of 1,25(OH)(2)D-3 in experimental mesangial proliferative nephritis in rats 113
Acute suppression of parathyroid activity during hemofiltration 113
Protein layer on hemodialysis membranes: a new immunohistochemistry technique. 113
Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis 113
C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes 110
Plasma C-reactive protein in hemodialysis patients: A cross-sectional, longitudinal clinical survey 109
Ochratoxin A-induced renal cortex fibrosis and epithelial-to-mesenchymal transition: Molecular mechanisms of ochratoxin A-injury and potential effects of red wine 108
Impact of Dialysis Technique on Renal Anemia 108
Ultrasonic Myocardial Texture Parameters in Hemodialytic Patients Compared withEssential Hypertensive Patients. 1st International Congress on Heart Disease – New Trends in Research, Diagnosis and Treatment. Washington DC, USA, May 16-19, 1999. 108
Plasma C-reactive protein is linked to backfiltration associated interleukin-6 production 107
Inflammatory pattern in hemodiafiltration 107
Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients 105
Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus" 104
EFFECT OF INCREASING DOSES OF LISINOPRIL ON PROTEINURIA OF NORMOTENSIVE PATIENTS WITH IGA NEPHROPATHY AND NORMAL RENAL-FUNCTION 104
ANCA in dialysis patients: a role for bioincompatibility? 104
ACUTE-RENAL-FAILURE AFTER MEZLOCILLINE 104
Totale 14.775
Categoria #
all - tutte 53.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021539 0 0 0 0 0 20 70 94 55 78 43 179
2021/20221.338 12 76 14 95 265 180 20 74 86 27 53 436
2022/20231.808 263 221 97 172 316 211 25 137 240 7 106 13
2023/20242.813 242 210 225 127 256 224 29 27 18 1.278 38 139
2024/20254.476 14 169 22 232 468 482 426 275 393 611 522 862
2025/20262.746 345 684 531 330 467 389 0 0 0 0 0 0
Totale 18.749